Palo Alto Investors LP - SUNESIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$231,000
+59.3%
116,2460.0%0.01%
+50.0%
Q3 2020$145,000
-52.6%
116,246
-90.0%
0.01%
-55.6%
Q2 2020$306,000
-36.5%
1,162,4730.0%0.02%
-55.0%
Q1 2020$482,000
+22.6%
1,162,4730.0%0.04%
+81.8%
Q4 2019$393,000
-53.0%
1,162,4730.0%0.02%
-60.7%
Q3 2019$837,000
-0.9%
1,162,4730.0%0.06%
+36.6%
Q2 2019$845,000
-40.2%
1,162,4730.0%0.04%
-30.5%
Q1 2019$1,412,000
+192.3%
1,162,4730.0%0.06%
+126.9%
Q4 2018$483,000
-79.2%
1,162,4730.0%0.03%
-72.3%
Q3 2018$2,325,000
-5.6%
1,162,4730.0%0.09%
-4.1%
Q2 2018$2,464,000
-22.1%
1,162,4730.0%0.10%
-27.4%
Q1 2018$3,162,000
-26.3%
1,162,4730.0%0.14%
-27.0%
Q4 2017$4,290,000
+90.2%
1,162,4730.0%0.18%
+94.7%
Q3 2017$2,255,000
-28.2%
1,162,4730.0%0.10%
-35.4%
Q2 2017$3,139,000
-34.1%
1,162,4730.0%0.15%
-34.7%
Q1 2017$4,766,000
+13.3%
1,162,4730.0%0.22%
-6.2%
Q4 2016$4,208,000
-17.2%
1,162,4730.0%0.24%
-18.6%
Q3 2016$5,080,0001,162,4730.30%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,133,583$4,104,0003.61%
GREAT POINT PARTNERS LLC 1,537,873$5,567,0001.14%
BVF INC/IL 1,392,720$5,042,0001.01%
Boxer Capital, LLC 525,000$1,901,0000.74%
Vivo Capital, LLC 500,000$1,810,0000.60%
Healthcare Value Capital, LLC 150,000$543,0000.58%
Cormorant Asset Management, LP 1,000,000$3,620,0000.49%
Telemetry Investments, L.L.C. 120,807$437,0000.25%
Palo Alto Investors LP 1,162,473$4,208,0000.24%
NEA Management Company, LLC 1,298,274$4,700,0000.19%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders